VKH
INO icon

Virtu KCG Holdings’s Inovio Pharmaceuticals INO Stock Holding History

Virtu KCG Holdings’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$556K Buy
+5,909
New +$505K 0.02% 1048
2017
Q1 		– Sell
-2,527
Closed -$210K – 3431
2016
Q4 		$210K Buy
2,527
+794
+46% +$71.8K 0.01% 2528
2016
Q3 		$194K Sell
1,733
-8,197
-83% -$906K ﹤0.01% 2376
2016
Q2 		$1.1M Buy
9,930
+8,790
+771% +$1.07M 0.02% 680
2016
Q1 		$119K Sell
1,140
-5,027
-82% -$388K ﹤0.01% 2282
2015
Q4 		$497K Buy
6,167
+2,753
+81% +$219K 0.01% 1554
2015
Q3 		$237K Buy
3,414
+1,428
+72% +$124K ﹤0.01% 2376
2015
Q2 		$194K Sell
1,986
-1,025
-34% -$110K ﹤0.01% 2614
2015
Q1 		$295K Buy
3,011
+1,658
+123% +$161K 0.01% 1939
2014
Q4 		$149K Sell
1,353
-580
-30% -$70.9K ﹤0.01% 3047
2014
Q3 		$228K Buy
1,933
+327
+20% +$40.7K ﹤0.01% 2741
2014
Q2 		$208K Buy
1,606
+1,074
+202% +$127K ﹤0.01% 3027
2014
Q1 		$85K Buy
+532
New +$76.4K ﹤0.01% 3243
2013
Q4 		– Sell
-1,223
Closed -$122K – 4000
2013
Q3 		$122K Buy
+1,223
New +$103K ﹤0.01% 3319

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Virtu KCG Holdings's INO Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Inovio Pharmaceuticals (INO) in Q2 2017: 5,909 shares worth $556K. The stake represents 0.02% of the portfolio and ranks #1048 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in INO as recently as Q4 2016.

Virtu KCG Holdings first reported a position in INO in Q3 2013 and has held it in 14 quarters since. The position peaked at $1.1M in Q2 2016. 118 funds tracked by Wall St. Rank hold INO as of Q2 2017.

  • Virtu KCG Holdings held 5,909 shares of Inovio Pharmaceuticals worth $556K as of Q2 2017.
  • Inovio Pharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
  • Inovio Pharmaceuticals made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #1048 holding.
  • Virtu KCG Holdings first reported a position in Inovio Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • Virtu KCG Holdings's Inovio Pharmaceuticals position peaked at $1.1M in Q2 2016.
  • 118 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.